India Mulls New FDI Restrictions As Investments Double In Five Months
This article was originally published in PharmAsia News
Executive Summary
India regulators are considering placing conditions on future foreign direct investments in its drug industry, which recorded a doubling of acquisitions of local firms and other arrangements from April through August.